retatrutide parkinson clinical trial Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a Retatrutide Achieves Up to 30.3%

Deficient Production of GLP-1 Patients that have long standing Type II diabetes and poor glycemic control are deficient in their production of GLP-1

It signals to your brain that you're full, slows digestion, and helps regulate blood sugar levels

Future studies specifically designed to evaluate hormonal contributions (e.g., estrogenGLP-1 receptor interactions) will be important to mechanistically clarify these sex differences

The authors would like to acknowledge helpful discussions with Guo Yang, Savitha Ramasamy, and Zhou Weizhuang, and support on compliance and governance from Nurensah Beevi at the Institute for Infocomm Research, A*STAR

Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism